Biotech IPO window is open but big pharma M&A sets the pace: Bankers
Public markets are beginning to reopen for biotech companies after several years of muted activity. But the strongest…
Read More...
Read More...
Browsing Tag
ARK Genomic Revolution ETF
GSK to acquire U.S. drugmaker Nuvalent for $10.6 billion
GlaxoSmithKline headquarters in London on Jan. 17, 2022.Hannah Mckay | ReutersU.K. pharmaceutical group GSK has…
Read More...
Read More...
Biotech M&A hits $106 billion, on track for best year since pre-Covid
Global biopharma M&A is experiencing a sharp uptick, putting the sector on track for its strongest year since the…
Read More...
Read More...
FDA vaccine head will step down in April after string of controversial
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services…
Read More...
Read More...
Zealand stock falls 35% after trial setback, CEO remains optimistic
Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight…
Read More...
Read More...